UC San Diego Division of Hospital Medicine Faculty

 


Dr. Jenkins

Highlighted
Publications

 


Ian Jenkins, MD, SFHM
Health Sciences Clinical Professor

 

Telephone (619) 471-9186

Mail Code 8485

 

 

Academic Profile

Dr. Ian Jenkins earned his MD degree from the University of Virginia Medical School in Charlottesville, Virginia, where he was elected to the Alpha Omega Alpha honor society. He completed his residency in internal medicine at Beth Israel Deaconess Medical Center in Boston, Massachusetts, in 2004. 

 

Dr. Jenkins is the chair of the Patient Safety Committee and serves on several others (Significant Events, Quality Council, and Transfusion). He now devotes 25% of his time to quality improvement at UCSD, working on projects such as MD-RN communication, alcohol withdrawal, VTE prevention, VTE management and anticoagulation safety, transfusion optimization, sepsis management, hand hygiene, CAUTI, and central line safety. External projects have included CAUTI/CLABSI reduction with AHRQ and SHM, and serving as a VTE prevention mentor for dozens of hospitals in collaborative efforts with SHM, Sutter Health, Dignity Health, and a facilities from Delaware to Rhode Island. 

 

Dr. Jenkins co-directs "Principles to Practice," the pre-internship class for graduating medical students, and won the Kaiser Teaching Award from the 4th year classes of 2016 and 2017. 



Highlighted Publications

  • Jenkins I, O’Bryan T, Holdych J, Maynard G. A Multi-Center, Mentored Quality Collaborative to Reduce Hospital-Associated VTE. Research and Innovations Plenary Presentation and winner, 3 of >1700 abstracts, SHM annual meeting, Las Vegas, NV, May 2017.
  • Reisinger JD, Wojcik A, Jenkins I, et al. The Project Protect Infection Prevention Fellowship: A Model for Advancing Quality Improvement Initiatives. Am J Inf Control 2017 May. S0196-6553(17)30287-0 [epub ahead of print].
  • Jenkins I, Doucet J, Clay B et al. Transfusing Wisely: Clinical Decision Support Improves Blood Transfusion Practices. Jt Comm J Qual Patient Saf 2017. [epub ahead of print].  
  • Jenkins I, Maynard G, White R et al. “Reducing the Incidence of Hospital-Associated Venous Thromboembolism within a Network of Academic Hospitals: Findings from Five University of California Medical Centers.” J Hosp Med. 2016 Dec;11 Suppl 2:S22-S28. (co-Winner, 2015 CDC VTE Prevention Challenge)
  • Jenkins I. Reflections on Marriage Equality.  Ann Int Med 2016; 164:129-30.
  • Jenkins I, Shander A, Goodnough L, et al.  Inpatient Anemia Management Implementation Guide.  Joint SHM / Society for the Advancement of Blood Management project, 2015. (see online document)
  • Jenkins I, Monash B, Wu J, Amin A.  The Third Hand: Low Rates of Stethoscope Hygiene on General Medicine Services.  J Hosp Med 2015; 10:457-8.
  • Maynard G, Humber D, Jenkins I.  Multidisciplinary Initiative to improve inpatient anticoagulation and management of venous thromboembolism.  Am J Health Syst Pharm 2014;71(4):305-10.
  • Maynard G, Jenkins I, Merli G.  Venous Thromboembolism Prevention Guidelines for Medical Inpatients: Mind the (Implementation) Gap.  J Hosp Med 2013; 8(10): 582-8.
  • Jenkins, I.  Heparin Induced Thrombocytopenia. In: Wiese, Auerbach, Glasheen, and Li (Eds): Clinical Decision Support: Hospital Medicine, 2013, revision with O’Rourke, C, 2015 (online reference). 
  • Khanna RR, Kim SB, Jenkins I, et al.  Predictive Value of the POA Indicator for Hospital-Acquired Venous Thromboembolism.  Med Care 2013 (epub ahead of print).  
  • Jenkins, I.  A Grumpy Old Man.  J Hosp Med 2012 Feb;7(2):154-5.
  • Jenkins I, Helmons PJ, Martin-Armstrong LM, Montazeri ME,Renvall M. High rates of venous thromboembolism prophylaxis did not increase the incidence of heparin-induced thrombocytopenia. The Joint Commission Journal on Quality and Patient Safety 2011; 37(4): 163- 169.
  • Maynard G, Jenkins I, Stone S, Lee J, Fink E, Morris T, Schoenhaus R, Renvall M. Optimizing prevention of hospital-acquired venous thromboembolism. First-place research presentation at the Society of Hospital Medicine Annual Meeting, April 3-5, 2008, San Diego. J Hospital Med 2008; 3(S1):29.   PDF (see PDF document p. 31)
  • Jenkins I. Linezolid and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin. J Hosp Med 2007; 2(5):343-4.
  • Jenkins I. Evidence-based sepsis therapy: A Hospitalist Perspective. J Hosp Med 2006; 1(5):285-295. Abstract
  • Jenkins I. Ghost story. J Hosp Med 2006; 1(5):323-325.